Growth hormone secretagogue receptor agonist · 5mg lyophilised
Ipamorelin is a pentapeptide ghrelin receptor superfamily ligand studied for selective GH release profiles in pituitary models compared with older secretagogues. Research use only.
This SKU is currently unavailable.
Browse other products →Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that acts as an agonist at the ghrelin receptor (GHS-R1a) on pituitary somatotrophs. Unlike earlier GHRP generations, Ipamorelin was designed for high selectivity: in many preclinical models it stimulates GH release with comparatively modest effects on cortisol, prolactin, and adrenocorticotropic hormone when dosed within studied ranges.
Because of its clean pharmacological profile, Ipamorelin is frequently used as a reference ligand when ranking other secretagogues, testing receptor mutants, or exploring pulsatile GH dynamics in perfused pituitary systems. Optimus Peptides supplies Ipamorelin exclusively for lawful research - not for athletic, cosmetic, or clinical use outside approved studies.
The ghrelin receptor is a Gq/11-coupled GPCR that triggers GH secretion when activated in somatotrophs. Ipamorelin literature highlights:
Published animal data suggest a cleaner endocrine profile at some doses, but no general safety claim can be made for research material outside a controlled protocol. Always follow dose–response characterisation in your own system.
No. This product is not for human consumption or performance enhancement. Sale and possession may be restricted in your jurisdiction.
It works through a different receptor class. Many studies pair secretagogues with GHRH analogues to probe axis integration; they are complementary tools, not interchangeable.
Use the notify button above to receive an email alert.